...
首页> 外文期刊>Human Genetics >Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).
【24h】

Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).

机译:台湾猎人综合症(II型粘多糖贮积病)潜在突变的表达研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Nearly 300 different mutations underlying mucopolysaccharidosis type II (MPS II) have been identified worldwide. To investigate the molecular lesions underlying Taiwanese MPS II, probands and families were identified and screened for iduronate-2-sulfatase (IDS) mutation by single-strand conformation polymorphism and DNA sequencing. Five novel and five previously reported mutations were found. Together with those previously reported, a total of 17 identified missense, small deletion, and nonsense mutations were further characterized by transient expression studies. Transfection of COS-7 cells by the mutated cDNA did not yield active enzyme, demonstrating the deleterious nature of the mutations. A 57% decrease in IDS mRNA level was seen with the 231del6 mutation. Among the 11 missense mutations examined, K347E substitution showed apparent normal maturation and targeting on immunoblot and confocal fluorescence microscopy examination. The other 10 missense mutations showed apparent normal precursor with little or reduced mature forms, indicating normal maturation but incorrect targeting of the mutant enzymes. Among the six deletion and nonsense mutations examined, 1055del12 and E521X showed abnormal maturation. The staining pattern of the truncated W267X and 1184delG proteins suggested retention within early vacuolar compartments. The mutated 231del6 and 1421delAG proteins were unstable and largely degraded. Molecular analysis of the IDS gene will clearly identify the cause of the disease within patients and allow antenatal and family studies. The further characterization of gene mutations may delineate their functional consequences on IDS activity and processing and may enable future studies of genotype-phenotype correlation to estimate a prognosis and to lead to possible therapeutic interventions.
机译:在世界范围内已经发现了将近300种II型黏多糖贮积病(MPS II)基础突变。为了调查台湾MPS II潜在的分子损伤,鉴定了先证者和家属,并通过单链构象多态性和DNA测序筛选了异戊二酸酯-2-硫酸酯酶(IDS)突变。发现了五个新颖的突变和五个先前报道的突变。与先前报道的结果一起,通过瞬时表达研究进一步鉴定了总共17个已识别的错义,小缺失和无义突变。通过突变的cDNA转染COS-7细胞未产生活性酶,证明了突变的有害性质。 231del6突变使IDS mRNA水平降低了57%。在检查的11个错义突变中,K347E取代表现出明显的正常成熟,并以免疫印迹和共聚焦荧光显微镜检查为靶标。其他10个错义突变显示出明显的正常前体,几乎没有或减少了成熟形式,表明成熟正常但突变酶的靶向不正确。在所检查的六个缺失和无意义突变中,1055del12和E521X显示异常成熟。截短的W267X和1184delG蛋白的染色模式表明保留在早期液泡区室中。突变的231del6和1421delAG蛋白是不稳定的,并在很大程度上降解。 IDS基因的分子分析将清楚地确定患者体内疾病的原因,并允许进行产前和家庭研究。基因突变的进一步表征可以描述其对IDS活性和加工的功能影响,并可能使基因型与表型相关性的进一步研究能够估计预后并导致可能的治疗干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号